🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assess the percentage change in stage and risk stratification for patients ...
Status
Recruiting
Location
Assiut university
Start Date
2024-10-10
Trial ID
NCT06632431
Treatments Being Tested
This is a multicenter, prospective, specimen collection study for developme...
Status
Recruiting
Location
Physical Care Clinical Research
Start Date
2026-03-10
Trial ID
NCT07544680
The goal of this clinical trial is to learn if intrauterine injection of "R...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-01-30
Trial ID
NCT07377734
Based on the above situation, the investigators propose the following scien...
Status
Recruiting
Location
Tenth People's Hospital of Tongji University
Start Date
2025-04-21
Trial ID
NCT06914297
Treatments Being Tested
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-25
Trial ID
NCT05554328
This trial is a non-randomized, open label and multicenter study. It aims ...
Status
Active Not Recruiting
Location
Service de chirurgie et oncologie gynécologique et mammaire
Start Date
2019-05-23
Trial ID
NCT03776630
Treatments Being Tested
Single Center, open label, Phase I-II trial designed to test the safety and...
Status
Recruiting
Location
Amsterdam UMC, AMC
Start Date
2019-08-01
Trial ID
NCT04014530
Treatments Being Tested
Purpose: The purpose of this study is to evaluate FFNP PET/MRI's utility fo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-02-15
Trial ID
NCT05483023
Treatments Being Tested
In recent years, knowledge about cancer biology has expanded significantly....
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06
Trial ID
NCT07006103
This is a multicenter, open label, pilot phase II study of the PI3K inhibit...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2022-02-10
Trial ID
NCT04750941
Treatments Being Tested